211 related articles for article (PubMed ID: 22201747)
1. WW domain-containing proteins: retrospectives and the future.
Salah Z; Alian A; Aqeilan RI
Front Biosci (Landmark Ed); 2012 Jan; 17(1):331-48. PubMed ID: 22201747
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of the WW domain-containing protein genes in silkworm and their expansion in eukaryotes.
Meng G; Dai F; Tong X; Li N; Ding X; Song J; Lu C
Mol Genet Genomics; 2015 Jun; 290(3):807-24. PubMed ID: 25424044
[TBL] [Abstract][Full Text] [Related]
3. WW domains provide a platform for the assembly of multiprotein networks.
Ingham RJ; Colwill K; Howard C; Dettwiler S; Lim CS; Yu J; Hersi K; Raaijmakers J; Gish G; Mbamalu G; Taylor L; Yeung B; Vassilovski G; Amin M; Chen F; Matskova L; Winberg G; Ernberg I; Linding R; O'donnell P; Starostine A; Keller W; Metalnikov P; Stark C; Pawson T
Mol Cell Biol; 2005 Aug; 25(16):7092-106. PubMed ID: 16055720
[TBL] [Abstract][Full Text] [Related]
4. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
5. Biophysical studies and modelling indicate the binding preference of TAZ WW domain for LATS1 PPxY motif.
Verma A; Lin F; Tan YC; Hidayat MN; Jobichen C; Fan H; Sivaraman J
Biochem Biophys Res Commun; 2018 Jul; 502(3):307-312. PubMed ID: 29787761
[TBL] [Abstract][Full Text] [Related]
6. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.
Chan SW; Lim CJ; Huang C; Chong YF; Gunaratne HJ; Hogue KA; Blackstock WP; Harvey KF; Hong W
Oncogene; 2011 Feb; 30(5):600-10. PubMed ID: 20972459
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of Saccharomyces cerevisiae WW domains and their interacting proteins.
Hesselberth JR; Miller JP; Golob A; Stajich JE; Michaud GA; Fields S
Genome Biol; 2006; 7(4):R30. PubMed ID: 16606443
[TBL] [Abstract][Full Text] [Related]
8. WW domain interactions regulate the Hippo tumor suppressor pathway.
Salah Z; Aqeilan RI
Cell Death Dis; 2011 Jun; 2(6):e172. PubMed ID: 21677687
[TBL] [Abstract][Full Text] [Related]
9. WW or WoW: the WW domains in a union of bliss.
Sudol M; Recinos CC; Abraczinskas J; Humbert J; Farooq A
IUBMB Life; 2005 Dec; 57(12):773-8. PubMed ID: 16393779
[TBL] [Abstract][Full Text] [Related]
10. Solution structure and ligand recognition of the WW domain pair of the yeast splicing factor Prp40.
Wiesner S; Stier G; Sattler M; Macias MJ
J Mol Biol; 2002 Dec; 324(4):807-22. PubMed ID: 12460579
[TBL] [Abstract][Full Text] [Related]
11. A map of WW domain family interactions.
Hu H; Columbus J; Zhang Y; Wu D; Lian L; Yang S; Goodwin J; Luczak C; Carter M; Chen L; James M; Davis R; Sudol M; Rodwell J; Herrero JJ
Proteomics; 2004 Mar; 4(3):643-55. PubMed ID: 14997488
[TBL] [Abstract][Full Text] [Related]
12. Yorkie-Warts Complexes are an Ensemble of Interconverting Conformers Formed by Multivalent Interactions.
Baker K; Kwok E; Reardon P; Rodriguez DJ; Rolland AD; Wilson JW; Prell JS; Nyarko A
J Mol Biol; 2021 Feb; 433(4):166776. PubMed ID: 33383033
[TBL] [Abstract][Full Text] [Related]
13. A novel pro-Arg motif recognized by WW domains.
Bedford MT; Sarbassova D; Xu J; Leder P; Yaffe MB
J Biol Chem; 2000 Apr; 275(14):10359-69. PubMed ID: 10744724
[TBL] [Abstract][Full Text] [Related]
14. Comparative structural and energetic analysis of WW domain-peptide interactions.
Schleinkofer K; Wiedemann U; Otte L; Wang T; Krause G; Oschkinat H; Wade RC
J Mol Biol; 2004 Nov; 344(3):865-81. PubMed ID: 15533451
[TBL] [Abstract][Full Text] [Related]
15. WW domain sequence activity relationships identified using ligand recognition propensities of 42 WW domains.
Otte L; Wiedemann U; Schlegel B; Pires JR; Beyermann M; Schmieder P; Krause G; Volkmer-Engert R; Schneider-Mergener J; Oschkinat H
Protein Sci; 2003 Mar; 12(3):491-500. PubMed ID: 12592019
[TBL] [Abstract][Full Text] [Related]
16. Common mechanism of ligand recognition by group II/III WW domains: redefining their functional classification.
Kato Y; Nagata K; Takahashi M; Lian L; Herrero JJ; Sudol M; Tanokura M
J Biol Chem; 2004 Jul; 279(30):31833-41. PubMed ID: 15133021
[TBL] [Abstract][Full Text] [Related]
17. Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.
Schuchardt BJ; Bhat V; Mikles DC; McDonald CB; Sudol M; Farooq A
Biochemistry; 2013 Dec; 52(51):9223-36. PubMed ID: 24308844
[TBL] [Abstract][Full Text] [Related]
18. The structure and dynamics of tandem WW domains in a negative regulator of notch signaling, Suppressor of deltex.
Fedoroff OY; Townson SA; Golovanov AP; Baron M; Avis JM
J Biol Chem; 2004 Aug; 279(33):34991-5000. PubMed ID: 15173166
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.
Farooq A
Exp Biol Med (Maywood); 2015 Mar; 240(3):361-74. PubMed ID: 25662954
[TBL] [Abstract][Full Text] [Related]
20. WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.
Iglesias-Bexiga M; Castillo F; Cobos ES; Oka T; Sudol M; Luque I
PLoS One; 2015; 10(1):e0113828. PubMed ID: 25607641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
